PTEN-lipid-phosphatase activity is critical for its tumor-suppressor function, which antagonizes the PI3K–AKT/PKB signaling pathway by dephosphorylating phosphoinositides, thereby modulating the cell-cycle progression and cell survival [7]. The gene discussed is PTEN; the disease is neoplasm.